Debut Plus

₹157.98

▲ +7.52 +5.00%

11 Sept 2026

NSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
NSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-08-17

QMS Medical Allied Services Ltd. (QMSMEDI)

Volume: 30,304Avg Vol 1W: 18,852.4Avg Vol 1M: 35,344.452W Range:₹68.95₹165
NSE BSE www.qmsmas.com AI Report
Key Ratios
Checked 2h ago
Market Cap₹305 Cr
Current Price₹157.98
Previous Close₹150.46
High / Low (52w)₹165 / ₹68.95
Volume30,304
Avg Vol (1W)18,852.4
Avg Vol (1M)35,344.4
Stock P/E28.41
Book Value₹53.88
Dividend Yield33%
ROE9.67%
ROA5.91%
Revenue (TTM)₹158 Cr
Revenue Growth27.8%
Profit Margin5.87%
Total Debt₹9 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹5.56
P/B2.93
Debt / Equity0.56
50 DMA₹127.25
200 DMA₹99.26
Day change+5.00%
SurveillanceESM · ESM 1
Price Chart
₹157.98▲ 71.34% · 1Y
₹162₹721.6L
2025-09-11
2026-09-11

20-day avg volume: 35K shares

Pros
  • Pays a dividend yield of 33.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 40% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹37 Cr₹44 Cr₹45 Cr₹47 Cr₹45 Cr₹37 Cr₹44 Cr₹57 Cr
EBITDA₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹7 Cr
Net Profit₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹39 Cr₹42 Cr₹158 Cr₹42 Cr₹41 Cr₹30 Cr₹39 Cr₹52 Cr
EBITDA₹5 Cr₹7 Cr₹23 Cr₹6 Cr₹5 Cr₹3 Cr₹3 Cr₹6 Cr
Net Profit₹2 Cr₹3 Cr₹12 Cr₹3 Cr₹3 Cr₹1 Cr₹1 Cr₹3 Cr
EPS——6.77—————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹33 Cr₹60 Cr₹82 Cr₹118 Cr₹135 Cr₹190 Cr
Total Liabilities₹24 Cr₹40 Cr₹51 Cr₹47 Cr₹57 Cr₹83 Cr
Equity₹9 Cr₹20 Cr₹31 Cr₹70 Cr₹79 Cr₹107 Cr
Total Debt₹0 Cr₹1 Cr₹2 Cr₹1 Cr——
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹6 Cr₹2 Cr₹-5 Cr₹5 Cr₹26 Cr
Investing₹-8 Cr₹2 Cr₹-25 Cr₹-3 Cr₹-45 Cr
Financing₹7 Cr₹0 Cr₹32 Cr₹0 Cr₹26 Cr
Free Cash Flow₹6 Cr₹2 Cr₹-5 Cr₹5 Cr₹26 Cr
Shareholding
Promoter 68.11% Institutions 1.59% Public 30.3%
Efficiency & Working Capital
ROCE12.9%
Interest Coverage5
Dividend Payout—
Debtor Days101 d
Inventory Days92 d
Payable Days40 d
Cash Conversion Cycle154 d
Working Capital Days193 d
Shareholding Details

As of 2026-06-30

Promoter68.1%
FII0%
DII1.6%
Institutions1.6%
Public30.3%
Promoter Pledge0%
No. of Shareholders1,554
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodOct 2022Oct 2022Dec 2022Mar 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Mar 2026Jun 2026
Promoters73.7%73.7%73.7%73.7%73.7%73.7%73.7%73.7%73.7%68.1%68.1%68.1%
FIIs0%0%0.7%1.2%1%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%1.6%1.6%1.6%
Public26.3%26.3%25.6%25.1%25.3%26.3%26.3%26.3%26.3%30.3%30.3%30.3%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,1781,1789251,0411,2131,5861,6951,5191,4891,5641,4991,554
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Mahesh Pahalraj MakhijaShareholding of Promoter and Promoter Group66.5%1.28 Cr
Gaurang Shashikant VasaniPublic Shareholding3.3%6,36,693
Stellar Asset Management Fund - Amrit Kaal Opportunities FundPublic Shareholding1.6%3,06,922
Diti Mahesh MakhijaShareholding of Promoter and Promoter Group0.8%1,63,116
Guddi Mahesh MakhijaShareholding of Promoter and Promoter Group0.8%1,59,630
Board of Directors
NameDesignationYear
Mahesh MakhijaChairman & Managing Director2025
DEENA NATH PATHAKNon Executive Director2025
Prajwal J. PoojaryIndependent Non Exe. Director2025
Niken ShahIndependent Non Exe. Director2025
SARITA VIJAY MAHAJANIndependent Non Exe. Director2025
Toral J. BhadraCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Healthcare Equipments & Supplies₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10231818
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-14Board Meetings—
dividend2025-09-22₹0.5 (5%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2024000022
2024000000
2024000022
Company Information
Incorporated2017
ChairmanMahesh Makhija
AuditorH H Dedhia & Associates
Investor Email[email protected]
🌐 www.qmsmas.com ↗

📍 A1/A2/B1/B2 Navkala BhartiBldg, Plot No 16 Prabhat Colony, Mumbai, Maharashtra, 400055

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

PVR Inox LimitedPopular Vehicles & Services Ltd.Physicswallah LimitedPyramid Technoplast Ltd.Quality Foils (India) Ltd.Q-Line Biotech LimitedQuality Power Electrical Equipments Ltd.Quadrant Future Tek Ltd.Quadpro ITES LimitedQuess Corp LimitedQuest Laboratories Ltd.Quick Heal Technologies Ltd.All “Q” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search